Related Experiment Video
Updated: Mar 7, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E
Ming Li1, Ling Ouyang2, Zhigang Zheng3
1Department of Hepatobiliary Pancreas and Vessel Surgery, Chenggong Hospital of Xiamen University, Xiamen, Fujian, P.R. China.
Abstract:
FBW7 (F-box and WD repeat domain-containing 7), also known as CDC4, AGO and SEL10, is the substrate recognition component of an evolutionary conserved SCF (complex of SKP1, CUL1 and F-box protein)-type E3 ubiquitin ligase. It is a recognized tumor suppressor because it targets multiple oncoproteins for ubiquitination-mediated destruction and its mutations are frequently identified in a variety of human malignancies. However, the function of FBW7 in proliferation of cholangiocarcinoma (CCA) remains unknown. We found that overexpression of FBW7α induced CCA cell arrest in G1 phase of cell cycle and inhibited cell proliferation in vitro and CCA xenograft tumor growth, suggesting that FBW7α is a tumor suppressor in CCA progression. Overxpression of FBW7α resulted in the protein degradation of its substrates such as c-Myc and cyclin E which promote CCA cell proliferation. Restoration of the expression of c-Myc, but not cyclin E, rescued the proliferation of FBW7α-overexpression CCA cells. These results suggest that FBW7α plays an essential inhibitory role in CCA progression, indicating that targeting FBW7α substrate c-Myc may be a potential strategy for CCA treatment.
Insights
F-box and WD repeat domain-containing 7 (FBW7) acts as a tumor suppressor in cholangiocarcinoma (CCA) by inhibiting cell proliferation. Targeting its substrate c-Myc may offer a new therapeutic strategy for CCA treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- F-box and WD repeat domain-containing 7 (FBW7) is a crucial tumor suppressor targeting oncoproteins for degradation.
- FBW7 mutations are common in human cancers, but its role in cholangiocarcinoma (CCA) is not well understood.
Purpose of the Study:
- To investigate the function of FBW7 in cholangiocarcinoma (CCA) cell proliferation and tumor growth.
- To identify FBW7 targets involved in CCA progression.
Main Methods:
- Overexpression of FBW7α in CCA cells.
- Assessment of cell cycle progression and proliferation in vitro.
- Evaluation of CCA xenograft tumor growth in vivo.
- Analysis of c-Myc and cyclin E protein levels.
Main Results:
- FBW7α overexpression induced G1 cell cycle arrest and inhibited CCA cell proliferation and xenograft tumor growth.
- FBW7α overexpression led to the degradation of c-Myc and cyclin E.
- Restoring c-Myc, but not cyclin E, rescued proliferation in FBW7α-overexpressing CCA cells.
Conclusions:
- FBW7α functions as a tumor suppressor in CCA progression.
- FBW7α inhibits CCA by degrading c-Myc and cyclin E.
- Targeting FBW7α substrate c-Myc presents a potential therapeutic strategy for CCA.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Anaphase Promoting Complex
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Mitogens and the Cell Cycle
Negative Regulator Molecules

